News & Filings
SOLARA \u2014 Recent Activity
3 items in the last 14 days
Solara Active Pharma Sciences Ltd (BOM:541540) Q3 2026 Earnings Call Highlights: Strategic ...
Solara Active Pharma Sciences Ltd (BOM:541540) reports strong non-ibuprofen growth and debt reduction, while navigating ibuprofen market pressures and strategic evaluations.
Click to open →
Solara Active Pharma Sciences Ltd (BOM:541540) Q2 2026 Earnings Call Highlights: Navigating ...
Despite a challenging quarter marked by operational disruptions, Solara Active Pharma Sciences Ltd (BOM:541540) focuses on debt reduction and maintaining a strong presence in regulated markets.
Click to open →
Solara Active Pharma Sciences Ltd (BOM:541540) Q4 2025 Earnings Call Highlights: Strong Margin ...
Solara Active Pharma Sciences Ltd (BOM:541540) reports significant improvements in profitability and strategic pivots to navigate competitive pressures in the ibuprofen market.
Click to open →
Get alerts for important filings
Add SOLARA to your watchlist for board meeting & dividend alerts.
Open analysis →News from yfinance + BSE corporate announcements. Importance scoring is automated. YieldIQ is not registered with SEBI as an investment adviser.